Company
Ergomed PLC
LON:ERGO
Ergomed PLC provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. The company's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO).
204 stories · page 1 of 11
Has British biotech outgrown the Square Mile?
The UK capital markets fail to price British biotech innovators fairly
Small cap movers: Ergomed and Instem highlight grim trend
Private equity firms ar targeting undervalued UK life sciences companies
Ergomed seeing sold growth in 2023
The AIM-quoted firm is studying two antibodies in COVID-19 cases
Ergomed sees 'solid' revenue growth so far this year
Financial results for the full year 2023 are in line with market expectations
Ergomed a 'premium quality' business, suggests broker
Earnings growth should average 12% annually over the next three years
Ergomed well positioned in high growth niches, says broker
Orders grew to £284.5m (up 25% yoy), which provides strong visibility on revenues
Archive
Small Cap Feast - Ergomed and more...
27 September 2022*A corporate client of Hybridan LLP** Arranged by most recent first*** Alphabetically arrangedDish of the dayJoiners:No joiners today.Leavers:No leavers today.What’s cooking in the IPO kitchen?**Streaks Gaming plc, a UK-bas
Ergomed confident for rest of 2022 and beyond
Orders during the half rose to £285mln, up nearly 19% from the start of the year.
Ergomed revenues rise 25% as pharma services demand stays healthy
In February, it acquired ADAMAS, a quality assurance specialist
Ergomed appoints former GSK and Sanofi executive to board
Anne Whitaker has worked across the pharmaceutical, biotech and speciality pharma sectors for 30 years
Ergomed earnings exceed expectations; says order book worth £240mln
The pharma services specialist gave an upbeat assessment of prospects
Ergomed strengthens pharma quality arm with £25mln acquisition
ADAMAS is focused on areas such as Good Clinical Practice (GCP) and Good Pharmacovigilance Practice (GVP)